Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens

Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens

US Patent 9410139 · Granted Aug 9, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aptamer-based CAR T-cell switch2025
Viral vectors encoding cancer/testis antigens for use in a method of prevention 2024
Viral vector constructs for expression of genetic adjuvants activating the CD40 2023
Viral vector constructs for expression of genetic adjuvants activating the STING2023
Use of adjuvants for the prevention and/or treatment of autoimmune diseases2022
Monomeric and functional adenylate cyclase CyaA toxin2021
Method for preparing multiple antigen glycopeptide carbohydrate conjugates2021
In vivo detection of proteins interaction based on adenylate cyclase hybrid syst2020
Lentiviral vectors for regulated expression of a chimeric antigen receptor molec2020
Lyophilized lentiviral vector particles, compositions and methods2020
Vectors for molecule delivery to CD11b expressing cells2018
Vectors for molecule delivery to CD11b expressing cells2018